Justin Plank | Spring 2025 Every year, the United States spends an estimated $173 billion treating obesity-related diseases like diabetes and heart disease, more than the annual budgets of 42 U.S. states combined. Amid this crisis, GLP-1 receptor agonists have emerged as a potential game-changer, offering not only weight loss but also the possibility …
Aaron Mathew, Editor-in-Chief | Spring 2025 Overview: Dr. Katy Milkman is the James G. Dinan Professor at The Wharton School of the University of Pennsylvania and the co-director of the Behavioral Change for Good Initiative alongside Dr. Angela Duckworth. Her research interests span behavioral economics, psychology, and research methodology, which she explores in her NYT …
Shloka Mohanty | Spring 2025 Engel curves illustrate how the consumption of goods changes as income increases. A classic example from ECON 301 is instant ramen noodles: as income rises, the consumption of this staple typically declines, classifying it as an inferior good. However, this relationship can vary by country. In India, instant …